Scientists hunt genetic clues to why cancer drugs steal Kids' hearing
NCT ID NCT02425397
Summary
This study aimed to understand why some children develop severe hearing loss after receiving certain platinum-based chemotherapy drugs (cisplatin or carboplatin) for cancer. Researchers compared the genes of 60 children who developed this hearing loss with 120 children who did not, all of whom had been treated for specific childhood cancers. The goal was to identify genetic markers that could predict which children are at high risk, so future treatments could be adjusted or protective medications could be used.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.